Confirmation of Self-Reported Incident ALS Cases in the AARP-Diet and Health (AARP-DH) Cohort
NCT00377351 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21
Last updated 2017-07-02
Summary
Amyotrophic Lateral Sclerosis (ALS) is a rare but rapidly progressive neurological disease that often results in death within a few years after the diagnosis. The incidence of ALS in the US is approximately 2.0/100,000/year and is age dependent. Very few epidemiological studies have investigated the causes of ALS. Last year, Dr. Alberto Ascherio at Harvard School of Public Health successfully obtained a RO1 grant to investigate the risk of ALS by documenting ALS cases in five well-established large prospective cohorts: The Nurses' Health Study (NHS), the Health Professionals Follow-up Study (HPFS), the Cancer Prevention Study II Nutrition Cohort (CPS IIN), the Multiethnic Cohort (MEC), and the NIH-American Association of Retired Persons Diet and Health Study (AARP-DH). The primary aims of this grant are to prospectively clarify the associations between diet and smoking and risk of ALS in this to date the largest epidemiological study on ALS. Incident ALS cases will be documented via biennial questionnaires in the first three cohorts. While mortality data will be obtained in the MEC and AARP-DH cohorts by searching the National Death Index (NDI) Plus, it is also desirable to identify surviving incident cases in these two cohorts.
The objective of this specific proposal is to ascertain the self-reported incident ALS cases from the AARP-DH study and obtain consent for medical release following the procedures set up for Parkinson's disease (PD) cases in the currently approved Parkinson's Genes and Environment (PAGE) Study IRB approval #06-E-N093. The confirmed ALS cases may be analyzed as part of the RO1 project. We expect to identify 300 self-reported ALS cases from the AARP cohort. Detailed analytic plans will be coordinated with Dr. Ascherio.
Conditions
Sponsors & Collaborators
-
National Institute of Environmental Health Sciences (NIEHS)
lead NIH
Eligibility
- Min Age
- 50 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-09-11
- Completion
- 2010-08-03
Countries
- United States
Study Locations
More Related Trials
-
ALS Testing Through Home-based Outcome Measures
NCT03016897 ·Status: COMPLETED
-
Cell Signaling, Reinnervation and Metabolism in Kennedy Disease and Amyotrophic Lateral Sclerosis (ALS)
NCT05107349 ·Status: RECRUITING ·Phase: NA
-
ASSESS ALL ALS Study
NCT06578195 ·Status: RECRUITING
-
Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)
NCT01884571 ·Status: COMPLETED ·Phase: PHASE2
-
Exogenous Toxicants and Genetic Susceptibility in ALS
NCT00011154 ·Status: COMPLETED
-
Determining the Safety of L-serine in ALS
NCT01835782 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS)
NCT03088839 ·Status: UNKNOWN
-
Safety and Dosimetry of a New Radiotracer to Detect Misfolded SOD1 Associated With Amyotrophic Lateral Sclerosis
NCT05974579 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Mitochondrial Functions and Oxidative Stress in ALS Patients
NCT00331812 ·Status: UNKNOWN
-
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
NCT05137665 ·Status: RECRUITING
-
Measurement and Impact of Physical Impairment in Amyotrophic Lateral Sclerosis: Use of Digital Technologies - A Precision ALS Project
NCT06820008 ·Status: RECRUITING
-
COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry
NCT04559009 ·Status: COMPLETED
-
Analysis of Human ALS Tissues and Registry of ALS Patients
NCT05067179 ·Status: RECRUITING
-
Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS)
NCT03366506 ·Status: RECRUITING
-
Study of ALS Reversals 4: LifeTime Exposures
NCT03706391 ·Status: COMPLETED
-
sCD163 in ALS Patients
NCT02325375 ·Status: COMPLETED
-
The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study
NCT00317616 ·Status: RECRUITING
-
LONgitudinal and Integrated Evaluation of Biomarkers in reLation to phenotYpe in ALS
NCT07312240 ·Status: RECRUITING ·Phase: NA
-
A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS
NCT05053035 ·Status: TERMINATED ·Phase: PHASE2
-
Amyotrophic Lateral Sclerosis (ALS) Gulf War Study
NCT00007722 ·Status: COMPLETED
-
Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients
NCT02424669 ·Status: UNKNOWN ·Phase: NA
-
Multiple Doses of AT-1501-A201 in Adults With ALS
NCT04322149 ·Status: COMPLETED ·Phase: PHASE2
-
The National Amyotrophic Lateral Sclerosis Registry
NCT01772602 ·Status: RECRUITING
-
Speech Analysis in ALS Patients
NCT03868345 ·Status: COMPLETED
-
Personalized Antisense Oligonucleotide for a Single Participant With CHCHD10 ALS
NCT06977451 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2